
Michael Schaffer, PharmD, MBA
Advertisement
Articles by Michael Schaffer, PharmD, MBA

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
2
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
3
60% of US Women Face Barriers to Postpartum, Mental Health Care
4
5 August FDA Approvals Marked by Novelty, Pushback
5